MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MS drug trial uses powerful 7T MRI to see inside the brain
Disease control Not yet recruitingThis study tests an experimental drug called remibrutinib in 20 people with relapsing or progressive multiple sclerosis (MS). Participants take the drug twice daily for 2 years and undergo ultra high-field 7T MRI scans to measure brain changes. The goal is to see if the drug can …
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Could CAR T-Cells be the key to taming MS?
Disease control Not yet recruitingThis early-stage study tests a new treatment called CABA-201 for people with multiple sclerosis (MS). It uses a patient's own immune cells, modified to target and destroy certain immune cells that may be attacking the nervous system. The main goal is to check safety and find the …
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Taurine: a new hope for MS patients?
Disease control Not yet recruitingThis study tests whether taking taurine alongside standard MS medications can reduce brain damage, relapses, and disability. About 80 adults with relapsing-remitting MS will take either their usual therapy alone or with added taurine for 24 months. Researchers will track MRI scan…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE2 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Lifestyle overhaul shows promise for MS symptoms
Symptom relief Not yet recruitingThis study tests a 12-week lifestyle program for 30 adults with relapsing-remitting multiple sclerosis (MS). The program focuses on nutrition, exercise, sleep, and stress management. Researchers want to see if it can reduce fatigue and improve quality of life, and how it affects …
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: New York University Abu Dhabi • Aim: Symptom relief
Last updated May 17, 2026 03:09 UTC
-
MS mystery: do relapses occur without MRI evidence?
Knowledge-focused Not yet recruitingThis study looks at whether people with relapsing-remitting multiple sclerosis (RRMS) can have a relapse without any new spots showing up on an MRI scan. Researchers will follow 136 adults who are having a flare-up, giving them an MRI within 6 days to check for active inflammatio…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 04, 2026 16:21 UTC
-
Eye scans could reveal hidden clues about MS treatment success
Knowledge-focused Not yet recruitingThis study tests whether a special eye scan (OCT) can detect changes in immune cells in the retina of people with multiple sclerosis (MS) who start a new medication called ublituximab (Briumvi). Researchers will compare 15 people starting ublituximab with 15 people on stable MS t…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated May 04, 2026 16:21 UTC